metyrapone has been researched along with Albright Syndrome in 7 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of McCune-Albright syndrome revealed by a Cushing's syndrome treated by metyrapone." | 7.73 | [Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome]. ( Azzabi, O; Ben Ammar, B; Ben Hariz, M; Ben Mrad, N; Halioui-Louhaichi, S; Maherzi, A; Nefzi, L, 2005) |
| "We present a case of McCune-Albright syndrome revealed by a Cushing's syndrome treated by metyrapone." | 3.73 | [Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome]. ( Azzabi, O; Ben Ammar, B; Ben Hariz, M; Ben Mrad, N; Halioui-Louhaichi, S; Maherzi, A; Nefzi, L, 2005) |
| "The most common cause of endogenous Cushing's disease in children older than 7 years is ACTH-dependent Cushing's disease (85%)." | 2.45 | [Cushing's syndrome: special issues]. ( Goñi Iriarte, MJ, 2009) |
| "Medical therapy can be used to treat Cushing syndrome and can result in improvement in the cardiovascular pathology." | 1.72 | Cushing syndrome as a failed cardiac screen in a patient with McCune-Albright syndrome: a case report. ( Al Zubeidi, H; Diaz-Thomas, A; Foster, C, 2022) |
| "We report a case of McCune-Albright syndrome with CS treated with metyrapone for 30 months with prolonged remission after a 12-year follow-up." | 1.43 | [Recovery of Cushing syndrome revealing McCune-Albright syndrome]. ( Azzabi, O; Dridi, Y; Fetni, I; Halioui-Louhaichi, S; Maherzi, A; Selmi, I; Siala, N, 2016) |
| "The baby girl underwent medical treatment of Cushing's syndrome with metyrapone which was followed by a rapid recovery." | 1.42 | Neonatal McCune-Albright syndrome with systemic involvement: a case report. ( Dias, P; Gouveia, R; Lourenço, R; Oliveira, G; Sousa, AB, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Foster, C | 1 |
| Al Zubeidi, H | 1 |
| Diaz-Thomas, A | 1 |
| Lourenço, R | 1 |
| Dias, P | 1 |
| Gouveia, R | 1 |
| Sousa, AB | 1 |
| Oliveira, G | 1 |
| Halioui-Louhaichi, S | 2 |
| Dridi, Y | 1 |
| Azzabi, O | 2 |
| Selmi, I | 1 |
| Fetni, I | 1 |
| Siala, N | 1 |
| Maherzi, A | 2 |
| Goñi Iriarte, MJ | 1 |
| Vong, CH | 1 |
| Forest, M | 1 |
| Nicolino, M | 1 |
| Nefzi, L | 1 |
| Ben Hariz, M | 1 |
| Ben Mrad, N | 1 |
| Ben Ammar, B | 1 |
| Gillis, D | 1 |
| Rösler, A | 1 |
| Hannon, TS | 1 |
| Koplewitz, BZ | 1 |
| Hirsch, HJ | 1 |
1 review available for metyrapone and Albright Syndrome
| Article | Year |
|---|---|
[Cushing's syndrome: special issues].
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Hyperfunction; Adult; Child; Cush | 2009 |
6 other studies available for metyrapone and Albright Syndrome
| Article | Year |
|---|---|
Cushing syndrome as a failed cardiac screen in a patient with McCune-Albright syndrome: a case report.
Topics: Cushing Syndrome; Dexamethasone; Fibrous Dysplasia, Polyostotic; GTP-Binding Protein alpha Subunits; | 2022 |
Neonatal McCune-Albright syndrome with systemic involvement: a case report.
Topics: Cafe-au-Lait Spots; Cushing Syndrome; Diagnosis, Differential; Failure to Thrive; Fatal Outcome; Fem | 2015 |
[Recovery of Cushing syndrome revealing McCune-Albright syndrome].
Topics: Child; Cushing Syndrome; Enzyme Inhibitors; Female; Fibrous Dysplasia, Polyostotic; Follow-Up Studie | 2016 |
Ketoconazole treatment for Cushing syndrome in McCune-Albright syndrome.
Topics: Adrenergic Agents; Adrenocorticotropic Hormone; Aminoglutethimide; Antifungal Agents; Chemical and D | 2009 |
[Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome].
Topics: Adrenal Hyperplasia, Congenital; Cushing Syndrome; Enzyme Inhibitors; Female; Fibrous Dysplasia, Pol | 2005 |
Prolonged remission of severe Cushing syndrome without adrenalectomy in an infant with McCune-Albright syndrome.
Topics: Adrenalectomy; Adrenergic Agents; Aminoglutethimide; Child; Cushing Syndrome; Enzyme Inhibitors; Fem | 2008 |